Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Model allows testing of fecal microbiota transplantation for Clostridium difficile infection

Oct. 23, 2015

UT Austin receives Gates Foundation grant to study hu1B7 as pertussis prophylaxis

Oct. 23, 2015

New phase IIa study investigates simeprevir, odalasvir and AL-335 treatment regimen in HCV

Oct. 21, 2015

European Commission approves isavuconazole for invasive aspergillosis and mucormycosis

Oct. 20, 2015

Genocea reports topline results from phase IIa trial of universal Pneumococcal vaccine

Oct. 20, 2015

Profiling of novel inhibitors of bacterial topoisomerases

Oct. 20, 2015

Sunshine Lake Pharma reports anti-HBV agents

Oct. 20, 2015

Novel polymyxin derivatives show antibacterial activity

Oct. 20, 2015

Cempra reports topline phase III data for intravenous solithromycin

Oct. 20, 2015

Genentech presents results from clinical trials of its anti-influenza antibody MHAA-4549A

Oct. 19, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...